Urinary Tract Infections and Inadequate Insulin Therapy as a Precipitating for Diabetic Ketoacidosis in Type 1 Diabetes Mellitus: A Case Report

Authors

  • Anak Agung Ayu Mita Astari Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia
  • Dewi Catur Wulandari Department of Internal Medicine, Wangaya General Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.71341/bmwj.v1i1.5

Keywords:

Diabetic Ketoacidosis, Type 1 diabetes mellitus, Insulin

Abstract

Background: Diabetic ketoacidosis (DKA) is a severe acute metabolic complication associated with diabetes mellitus. It is particularly prevalent in patients with Type 1 diabetes, where inadequate insulin therapy can lead to significant morbidity and mortality.

Case: We present the case of an 18-year-old girl diagnosed with Type 1 diabetes mellitus. She arrived at the hospital exhibiting shortness of breath and was found to have a C-peptide level of 0.33, which, alongside her history of irregular insulin injections, indicated poor adherence to insulin therapy. Upon physical examination, the patient appeared lethargic, had apathetic consciousness, a tachycardic heart rate of 127 beats per minute, and an elevated axillary temperature of 37.8°C. Notably, Kussmaul breathing was also observed.

Results: Laboratory findings revealed elevated white blood cell count (15,950/μL), hyperglycemia (blood sugar level of 379 mg/dL), and severe metabolic acidosis, as indicated by arterial blood gas analysis (pH 6.89, HCO3 1 mmol/L). Urinalysis demonstrated the presence of albumin (+1), glucose (+2), ketones (+3), leukocytes (+3), and bacteria. The patient required intensive care monitoring for five days before being transitioned to the general ward for an additional three days of treatment.

Conclusion: DKA is characterized by hyperglycemia, hyperketonemia, and metabolic acidosis, all of which are indicative of insufficient insulin therapy in patients with Type 1 diabetes. This case highlights the critical importance of adherence to insulin therapy for achieving optimal glycemic control. Effective management and discipline in treatment are essential to prevent DKA and reduce its associated mortality.

References

Ata, F., Khan, A. A., Khamees, I., Mohammed, B. Z. M., Barjas, H. H., Muthanna, B., Bashir, M., & Kartha, A. (2023). Differential evolution of diabetic ketoacidosis in adults with pre-existent versus newly diagnosed type 1 and type 2 diabetes mellitus. BMC Endocrine Disorders, 23(1), 1–10. https://doi.org/10.1186/s12902-023-01446-8

Belaunzarán-Zamudio, P. F., Caro-Vega, Y. N., Shepherd, B. E., Rebeiro, P. F., Crabtree-Ramírez, B. E., Cortes, C. P., Grinsztejn, B., Gotuzzo, E., Mejia, F., Padgett, D., Pape, J. W., Rouzier, V., Veloso, V., Cardoso, S. W., McGowan, C. C., & Sierra-Madero, J. G. (2020). The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America. American Journal of Epidemiology, 189(6), 564–572. https://doi.org/10.1093/aje/kwz252

Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, P., Tankova, T., Tsapas, A., & Buse, J. B. (2022). Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 65(12), 1925–1966. https://doi.org/10.1007/s00125-022-05787-2

Eledrisi, M., & Elzouki, A.-N. (2020). Management of diabetic ketoacidosis in adults: A narrative review. Saudi Journal of Medicine and Medical Sciences, 8(3), 165. https://doi.org/10.4103/sjmms.sjmms_478_19

Elendu, C., David, J. A., Udoyen, A.-O., Egbunu, E. O., Ogbuiyi-Chima, I. C., Unakalamba, L. O., Temitope, A. I., Ibhiedu, J. O., Ibhiedu, A. O., Nwosu, P. U., Koroyin, M. O., Eze, C., Boluwatife, A. I., Alabi, O., Okabekwa, O. S., Fatoye, J. O., & Ramon-Yusuf, H. I. (2023). Comprehensive review of diabetic ketoacidosis: an update. Annals of Medicine & Surgery, 85(6), 2802–2807. https://doi.org/10.1097/ms9.0000000000000894

Flores, M., Amir, M., Ahmed, R., Alashi, S., Li, M., Wang, X., Lansang, M. C., & Al-Jaghbeer, M. J. (2020). Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: Insulin pump users and non-users. BMJ Open Diabetes Research and Care, 8(2), 1–8. https://doi.org/10.1136/bmjdrc-2020-001329

Hepprich, M., Roser, P., Stiebitz, S., Felix, B., Schultes, B., Schmitz, D., Rutishauser, J., Schubert, S., Aberle, J., & Rudofsky, G. (2023). Awareness and knowledge of diabetic ketoacidosis in people with type 1 diabetes: a cross-sectional, multicenter survey. BMJ Open Diabetes Research and Care, 11(6), 1–9. https://doi.org/10.1136/bmjdrc-2023-003662

Kraut, J. A., & Madias, N. E. (2010). Metabolic acidosis: Pathophysiology, diagnosis and management. Nature Reviews Nephrology, 6(5), 274–285. https://doi.org/10.1038/nrneph.2010.33

Oliveira, S. M. R., Ahmadpour, E., Nissapatorn, V., & Pereira, M. D. L. (2023). Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices. Micromachines 2023, 14, 151. https:// doi.org/10.3390/mi14010151

Patel, M. P., Ahmed, A., Gunapalan, T., & Hesselbacher, S. E. (2018). Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review. World Journal of Diabetes, 9(11), 199–205. https://doi.org/10.4239/wjd.v9.i11.199

PB PERKENI. (2022). Tatalaksana Pasien Dengan Hiperglikemia di Rumah Sakit. 46-59. Diakses pada 20 Mei 2024. dari https://pbperkeni.or.id/wp-content/uploads/2023/05/Tatalaksana-Pasien-dengan-Hiperglikemia-di-Rumah-Sakit.pdf

Downloads

Published

2024-07-31

How to Cite

Astari, A. A. A. M., & Wulandari, D. C. (2024). Urinary Tract Infections and Inadequate Insulin Therapy as a Precipitating for Diabetic Ketoacidosis in Type 1 Diabetes Mellitus: A Case Report. Bali Medical and Wellness Journal, 1(1), 35–44. https://doi.org/10.71341/bmwj.v1i1.5